BACKGROUND: Major postoperative infections (MPIs) are poorly understood complications of cardiac surgery. We examined the epidemiology, microbiology, and outcome of MPIs occurring after cardiac surgery. METHODS: The study cohort was drawn from the Society of Thoracic Surgeon National Cardiac Database and comprised adults who underwent cardiac surgery at 5 tertiary hospitals between 2000 and 2004. We studied the incidence, microbiology, and risk factors of MPI (bloodstream or chest wound infections within 30 days after surgery), as well as 30-day mortality. We used multivariate regression analyses to evaluate the risk of MPI and mortality. RESULTS: MPI was identified in 341 of 10,522 patients (3.2%). Staphylococci were found in 52.5% of these patients, gram-negative bacilli (GNB) in 24.3%, and other pathogens in 23.2%. High body mass index, previous coronary bypass surgery, emergency surgery, renal impairment, immunosuppression, cardiac failure, and peripheral/cerebrovascular disease were associated with the development of MPI. Median postoperative duration of hospitalization (15 days vs 6 days) and mortality (8.5% vs 2.2%) were higher in patients with MPIs. Compared with uninfected individuals, odds of mortality were higher in patients with S aureus MPIs (adjusted odds ratio, 3.7) and GNB MPIs (adjusted odds ratio, 3.0). CONCLUSIONS: Staphylococci accounted for the majority of MPIs after cardiac surgery. Mortality was higher in patients with Staphylococcus aureus- and GNB-related MPIs than in patients with MPIs caused by other pathogens and uninfected patients. Preventive strategies should target likely pathogens and high-risk patients undergoing cardiac surgery.
BACKGROUND: Major postoperative infections (MPIs) are poorly understood complications of cardiac surgery. We examined the epidemiology, microbiology, and outcome of MPIs occurring after cardiac surgery. METHODS: The study cohort was drawn from the Society of Thoracic Surgeon National Cardiac Database and comprised adults who underwent cardiac surgery at 5 tertiary hospitals between 2000 and 2004. We studied the incidence, microbiology, and risk factors of MPI (bloodstream or chest wound infections within 30 days after surgery), as well as 30-day mortality. We used multivariate regression analyses to evaluate the risk of MPI and mortality. RESULTS:MPI was identified in 341 of 10,522 patients (3.2%). Staphylococci were found in 52.5% of these patients, gram-negative bacilli (GNB) in 24.3%, and other pathogens in 23.2%. High body mass index, previous coronary bypass surgery, emergency surgery, renal impairment, immunosuppression, cardiac failure, and peripheral/cerebrovascular disease were associated with the development of MPI. Median postoperative duration of hospitalization (15 days vs 6 days) and mortality (8.5% vs 2.2%) were higher in patients with MPIs. Compared with uninfected individuals, odds of mortality were higher in patients with S aureusMPIs (adjusted odds ratio, 3.7) and GNBMPIs (adjusted odds ratio, 3.0). CONCLUSIONS: Staphylococci accounted for the majority of MPIs after cardiac surgery. Mortality was higher in patients with Staphylococcus aureus- and GNB-related MPIs than in patients with MPIs caused by other pathogens and uninfected patients. Preventive strategies should target likely pathogens and high-risk patients undergoing cardiac surgery.
Authors: T B Ferguson; S W Dziuban; F H Edwards; M C Eiken; A L Shroyer; P C Pairolero; R P Anderson; F L Grover Journal: Ann Thorac Surg Date: 2000-03 Impact factor: 4.330
Authors: A Soriano; J A Martínez; J Mensa; F Marco; M Almela; A Moreno-Martínez; F Sánchez; I Muñoz; M T Jiménez de Anta; E Soriano Journal: Clin Infect Dis Date: 2000-02 Impact factor: 9.079
Authors: Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: Steinn Steingrimsson; Magnus Gottfredsson; Karl G Kristinsson; Tomas Gudbjartsson Journal: Scand Cardiovasc J Date: 2008-06 Impact factor: 1.589
Authors: Rabih O Darouiche; Matthew J Wall; Kamal M F Itani; Mary F Otterson; Alexandra L Webb; Matthew M Carrick; Harold J Miller; Samir S Awad; Cynthia T Crosby; Michael C Mosier; Atef Alsharif; David H Berger Journal: N Engl J Med Date: 2010-01-07 Impact factor: 91.245
Authors: Lonneke G M Bode; Jan A J W Kluytmans; Heiman F L Wertheim; Diana Bogaers; Christina M J E Vandenbroucke-Grauls; Robert Roosendaal; Annet Troelstra; Adrienne T A Box; Andreas Voss; Ingeborg van der Tweel; Alex van Belkum; Henri A Verbrugh; Margreet C Vos Journal: N Engl J Med Date: 2010-01-07 Impact factor: 91.245
Authors: David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson Journal: Ann Thorac Surg Date: 2009-07 Impact factor: 4.330
Authors: Zeina A Kanafani; Jean Marie Arduino; Lawrence H Muhlbaier; Keith S Kaye; Keith B Allen; Yehuda Carmeli; G Ralph Corey; Sara E Cosgrove; Thomas G Fraser; Anthony D Harris; Adolf W Karchmer; Ebbing Lautenbach; Mark E Rupp; Eric D Peterson; Walter L Straus; Vance G Fowler Journal: Infect Control Hosp Epidemiol Date: 2009-03 Impact factor: 3.254
Authors: Tessie B McNeely; Najaf A Shah; Arthur Fridman; Amita Joshi; Jonathan S Hartzel; Ravi S Keshari; Florea Lupu; Mark J DiNubile Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452
Authors: Keith B Allen; Vance G Fowler; James S Gammie; Jonathan S Hartzel; Matthew T Onorato; Mark J DiNubile; Ajoke Sobanjo-Ter Meulen Journal: Open Forum Infect Dis Date: 2014-08-26 Impact factor: 3.835
Authors: A Kornberger; B Luchting; F Kur; M Weis; F Weis; U A Stock; A Beiras-Fernandez Journal: J Cardiothorac Surg Date: 2016-08-04 Impact factor: 1.637